139 related articles for article (PubMed ID: 14990394)
21. Administration of an angiotensin-converting enzyme inhibitor improves vascular function and urinary albumin excretion in low-risk essential hypertensive patients receiving anti-hypertensive treatment with calcium channel blockers. Organ-protecting effects independent of anti-hypertensive effect.
Watanabe Y; Takasugi E; Shitakura K; Okajima K; Hota N; Kubo Y; Nunoda S; Otsuka K
Clin Exp Hypertens; 2011; 33(4):246-54. PubMed ID: 21699451
[TBL] [Abstract][Full Text] [Related]
22. Long-term angiotensin-converting enzyme inhibitor perindopril therapy improves cerebral perfusion reserve in patients with previous minor stroke.
Hatazawa J; Shimosegawa E; Osaki Y; Ibaraki M; Oku N; Hasegawa S; Nagata K; Hirata Y; Miura Y
Stroke; 2004 Sep; 35(9):2117-22. PubMed ID: 15256675
[TBL] [Abstract][Full Text] [Related]
23. [Reduced risk of stroke recurrence due to hypotensive medication, irrespective of the initial blood pressure].
Lenders JW; Thien T
Ned Tijdschr Geneeskd; 2002 Mar; 146(9):398-9. PubMed ID: 11901939
[TBL] [Abstract][Full Text] [Related]
24. Global impact of stroke.
Chalmers J
Heart Dis; 2000; 2(2):S13-7. PubMed ID: 11728258
[TBL] [Abstract][Full Text] [Related]
25. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy.
Dufouil C; Chalmers J; Coskun O; Besançon V; Bousser MG; Guillon P; MacMahon S; Mazoyer B; Neal B; Woodward M; Tzourio-Mazoyer N; Tzourio C;
Circulation; 2005 Sep; 112(11):1644-50. PubMed ID: 16145004
[TBL] [Abstract][Full Text] [Related]
26. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
[TBL] [Abstract][Full Text] [Related]
27. Effect of perindopril on cerebral and renal perfusion on normotensives in mild early ischaemic stroke: a randomized controlled trial.
Nazir FS; Overell JR; Bolster A; Hilditch TE; Lees KR
Cerebrovasc Dis; 2005; 19(2):77-83. PubMed ID: 15608430
[TBL] [Abstract][Full Text] [Related]
28. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial.
Arima H; Chalmers J; Woodward M; Anderson C; Rodgers A; Davis S; Macmahon S; Neal B;
J Hypertens; 2006 Jun; 24(6):1201-8. PubMed ID: 16685221
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of antihypertensive therapy among ischemic stroke survivors: impact of ischemic heart disease.
Hassan Y; Aziz NA; Al-Jabi SW; Looi I; Zyoud SH
J Cardiovasc Pharmacol Ther; 2010 Sep; 15(3):282-8. PubMed ID: 20472813
[TBL] [Abstract][Full Text] [Related]
30. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
[TBL] [Abstract][Full Text] [Related]
31. Reductions in the risks of recurrent stroke in patients with and without diabetes: the PROGRESS Trial.
Berthet K; Neal BC; Chalmers JP; MacMahon SW; Bousser MG; Colman SA; Woodward M;
Blood Press; 2004; 13(1):7-13. PubMed ID: 15083634
[TBL] [Abstract][Full Text] [Related]
32. [Control of arterial hypertension in stroke prevention].
Britov AN; Bystrova MM; Orlov AA
Klin Med (Mosk); 2002; 80(6):53-7. PubMed ID: 12138805
[TBL] [Abstract][Full Text] [Related]
33. Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease.
PROGRESS Collaborative Group
Eur Heart J; 2003 Mar; 24(5):475-84. PubMed ID: 12633548
[TBL] [Abstract][Full Text] [Related]
34. Effects of perindopril on elastic and structural properties of large arteries in essential hypertension.
Lacourcière Y; Béliveau R; Conter HS; Burgess ED; Lepage S; Pesant Y; Spence JD; Asmar R; Carrière S; Plante GE;
Can J Cardiol; 2004 Jun; 20(8):795-9. PubMed ID: 15229761
[TBL] [Abstract][Full Text] [Related]
35. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
36. Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment.
Poon IO
Pharmacotherapy; 2008 Mar; 28(3):366-75. PubMed ID: 18294116
[TBL] [Abstract][Full Text] [Related]
37. A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.
Wing LM; Reid CM; Ryan P; Beilin LJ; Brown MA; Jennings GL; Johnston CI; McNeil JJ; Macdonald GJ; Marley JE; Morgan TO; West MJ;
N Engl J Med; 2003 Feb; 348(7):583-92. PubMed ID: 12584366
[TBL] [Abstract][Full Text] [Related]
38. Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers especially useful for cardiovascular protection?
Ong HT
J Am Board Fam Med; 2009; 22(6):686-97. PubMed ID: 19897698
[TBL] [Abstract][Full Text] [Related]
39. Short-term antihypertensive efficacy of perindopril according to clinical profile of 3,188 patients: A meta-analysis.
Gasowski J; Wilkins A; Drzewoski J; Kłoś J; Gaciong Z; Kabat M; Grodzicki T
Cardiol J; 2010; 17(3):259-66. PubMed ID: 20535716
[TBL] [Abstract][Full Text] [Related]
40. Progress in secondary prevention of stroke with PROGRESS. The perindopril protection against recurrent stroke study.
Schiffrin EL
Curr Hypertens Rep; 2002 Feb; 4(1):39-40. PubMed ID: 11790290
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
